Page last updated: 2024-11-04

sulfathiazole and Anemia, Hemolytic

sulfathiazole has been researched along with Anemia, Hemolytic in 1 studies

Sulfathiazole: A sulfathiazole compound that is used as a short-acting anti-infective agent. It is no longer commonly used systemically due to its toxicity, but may still be applied topically in combination with other drugs for the treatment of vaginal and skin infections, and is still used in veterinary medicine.
sulfathiazole : A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position.

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FRACKIEWICZ, J1

Other Studies

1 other study available for sulfathiazole and Anemia, Hemolytic

ArticleYear
[Case of acute hemolytic anemia due to sulfathiazole therapy].
    Pediatria polska, 1950, Volume: 24, Issue:10

    Topics: Anemia; Anemia, Hemolytic; Humans; Sulfathiazole; Sulfathiazoles

1950